Potential depot medroxyprogesterone acetate–triggered torsades de pointes in a case of congenital type 2 long QT syndrome
- 31 July 2012
- journal article
- case report
- Published by Elsevier BV in Heart Rhythm
- Vol. 9 (7), 1143-1147
- https://doi.org/10.1016/j.hrthm.2012.02.006
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- Gender disparity in cardiac electrophysiology: Implications for cardiac safety pharmacologyPharmacology & Therapeutics, 2010
- Cardiovascular effects of medroxyprogesterone acetate and progesterone: a case of mistaken identity?Nature Clinical Practice Cardiovascular Medicine, 2008
- Progesterone Regulates Cardiac Repolarization Through a Nongenomic PathwayCirculation, 2007
- Long QT Syndrome and PregnancyJournal of the American College of Cardiology, 2007
- Intramuscular injections into the buttocks: Are they truly intramuscular?European Journal of Radiology, 2006
- Influence of Menstrual Cycle on QT Interval DynamicsPacing and Clinical Electrophysiology, 2006
- Identification of a common genetic substrate underlying postpartum cardiac events in congenital long QT syndromeHeart Rhythm, 2004
- Age- and Sex-Related Differences in Clinical Manifestations in Patients With Congenital Long-QT SyndromeCirculation, 1998
- Influence of Pregnancy on the Risk for Cardiac Events in Patients With Hereditary Long QT SyndromeCirculation, 1998
- Female gender as a risk factor for torsades de pointes associated with cardiovascular drugsJAMA, 1993